Phylos
Phylos Bioscience is a Portland-based cannabis and hemp genetics company founded in 2014 that develops F1 hybrid seeds, rare cannabinoid (THCV) genetics, and genomic tools for commercial cultivators, extraction brands, consumer product companies, and home growers. Revenue is generated through seed sales, branded ingredient licensing, and strategic Innovation Partner agreements.
- Company typePrivate
- Founded2014
- HeadquartersPortland, United States
- Headcount51–100
- GTM typeB2B
- OfferingHardware or Manufacturing
What Phylos does
Phylos Bioscience is a Portland, Oregon-based cannabis and hemp genetics company founded in 2014 that develops F1 hybrid seeds, rare cannabinoid (THCV) genetics, and genomic tools for commercial cultivators, extraction operators, consumer brands, and home growers. The company's core product is its Production-Ready Seed platform — fully-feminized, phenotypically stable F1 hybrid lines developed through marker-assisted selection and supported by an Illumina-partnered genotyping array that generates 50,000+ data points per plant. Phylos also operates the Phylos Galaxy, a 3D visualization tool containing genetic samples from 80+ countries mapped to six sub-populations, and a parallel rare-cannabinoid program anchored by the Natural Natural brand (THCV-dominant varieties GSD, Joyride, Powerhouse) with efficacy validated by an IRB-approved People Science clinical study.
The company monetizes through four primary revenue streams: direct and channel-based seed sales (commercial cultivators via enterprise sales plus home growers through an exclusive ILGM partnership), licensing of rare cannabinoid genetics to consumer brands, variety licensing for in-licensed genetics, and the Innovation Partner Program providing strategic operators like Organigram Global with priority access to the genetics pipeline and territorial exclusivity in Canada, Australia, UK, Germany, and Israel. Total committed capital includes $10M in senior secured convertible loans from Organigram (maturity May 2028), a $7.6M 2022 round led by Merida Capital Holdings with Accomplice and Entourage Effect Capital, and a 2024 SEC exempt offering of up to $4M. Pricing is not publicly disclosed; commercial seed pricing is quote-based while consumer sales flow through e-commerce at seeds.phylos.bio.
Phylos serves commercial cannabis cultivators, licensed hemp growers, extraction companies, and home growers across more than 10 U.S. states and five international markets. The company employs 51-100 staff including geneticists, breeders, and data scientists, operates an 80,000 ft² R&D glasshouse facility in partnership with Progressive Plant Research (a jointly controlled subsidiary), and has published proprietary genetic markers for stress tolerance, hermaphroditism resistance, autoflowering behavior (PRR37/PRR3 locus on chromosome 1), and washability (markers on chromosomes 6 and 7) — establishing a defensible position at the intersection of seed genetics and computational genomics for cannabis.
Phylos firmographics
Firmographics- Name
- Phylos
- Legal name
- Phylos Bioscience, Inc.
- Website
- https://phylos.bio
- Company type
- Private
- Founded year
- 2014
- Operating status
- Operating
- Headcount range
- 51–100 employees
- Short description
- Phylos Bioscience is a Portland-based cannabis and hemp genetics company founded in 2014 that develops F1 hybrid seeds, rare cannabinoid (THCV) genetics, and genomic tools for commercial cultivators, extraction brands, consumer product companies, and home growers. Revenue is generated through seed sales, branded ingredient licensing, and strategic Innovation Partner agreements.
- Ownership category
- akta.pro rank
Phylos industry classification
Industry- Product category
- Cannabis Seed Genetics
- NAICS
- Medicinal and Botanical Manufacturing (325411)
- SIC
- Patent Owners & Lessors (6794)
- akta.pro primary industry
- Seed Trait Licensing & IP Management (Licensing, freedom-to-operate) (AFABALAJ)
- akta.pro secondary industries
- Digital Breeding & Bioinformatics Software (Breeding informatics, decision tools) (AFABALAL), Phenotyping Technologies & Services (Field/Controlled Environment) (AFABALAF), Biotechnology & Gene-Edited Trait Development (AFAGAIAG)
Keywords
Where Phylos is headquartered
LocationHeadquarters
- HQ city
- Portland
- HQ country
- United States
- HQ region
- North America
Offices3 records
Markets served
Phylos business model
Business model- GTM type
- B2B
- Offering type
- Hardware or Manufacturing
- Cost components
- Personnel, Technology or R&D
Revenue model
- Seed Sales: Commercial-scale sales of F1 hybrid cannabis and hemp seeds to cultivators. Seeds are sold through direct sales team, e-commerce platform (seeds.phylos.bio), and channel partners like ILGM. Also offers commercial bulk orders.
- Rare Cannabinoid Ingredients (Natural Natural Brand): Consumer-facing ingredient brand commercializing patented naturally-derived rare cannabinoid genetics. Phylos Natural THCV varieties power high-quality supply chain of naturally-derived THCV through partnerships with growers, extractors, and consumer brands.
- Variety Licensing: In-licensing unique genetics from breeders for continued development and optimization, with fair compensation through licensing agreements.
- Innovation Partnership Access: Strategic partnerships providing priority access to genetics pipeline, exclusive rights to selected cultivars in specific markets, and co-development of seed-based production with cannabis operators like Organigram.
Pricing tiers
| Model | Billing | Price |
|---|---|---|
| Unit Pricing | Pay-as-you-go | Seed products available through e-commerce (seeds.phylos.bio) with commercial bulk orders for larger cultivators |
Go-to-market motion3 records
Distribution channels6 records
Marketing channels7 records
Phylos product offering
Product offeringCore offering
Phylos develops and sells premium F1 hybrid cannabis and hemp seeds (Production-Ready Seeds, Elite Seeds, AutoCBD, and autoflower varieties) using proprietary marker-assisted selection and DNA genotyping technology to deliver clone-quality uniformity from seed. The company also commercializes naturally-derived rare cannabinoid genetics (Phylos Natural THCV / Natural Natural brand) under licensing partnerships with consumer brands across multiple U.S. states and Canada.
Product overview
Phylos is a cannabis genetics company operating as a unified platform anchored by its Production-Ready Seed core product: premium, phenotypically stable, fully-feminized F1 hybrid seed lines for cannabis and hemp. The portfolio spans three tiers — Elite Seeds (for controlled environments), standard Feminized Seeds, and Autoflower Seeds (both THC and AutoCBD hemp) — all supported by rigorous quality testing. A parallel product line centers on THCV rare cannabinoids, anchored by the Natural Natural ingredient brand (Get Sh!t Done, Joyride, Powerhouse) backed by IRB-proven clinical efficacy. Supporting infrastructure includes the Phylos Galaxy genetic visualization platform, the Innovation Partner Program for strategic genetics licensing, and specialized Genotype and Plant Sex Tests. The platform is science-driven, using genetic marker technology to select plants at the seedling stage, enabling rapid breeding cycles and trait-specific optimization across seed and cannabinoid products.
Differentiator
Problem solved
Functional benefit
Brands
- Natural Natural: Consumer-facing ingredient brand commercializing patented, naturally-derived rare cannabinoid genetics including THCV. Natural Natural THCV varieties power a high-quality supply chain of naturally-derived THCV products.
- Production-Ready Seed
- Phylos Natural THCV
- Phylos Galaxy
Products and services
- Production-Ready F1 Hybrid Cannabis Seeds Phylos' flagship offering: premium, phenotypically stable, fully-feminized F1 hybrid cannabis seed lines engineered to deliver clone-quality uniformity in flower quality, potency, vigor, and yield for commercial-scale cultivation.
- Elite Seeds High-potency, production-ready F1 hybrid seed varieties designed for controlled environments (indoor and greenhouse), with stress tolerance, HLVd-resistance, reduced hermaphroditism, and yields that outperform clones at lower production cost.
- AutoCBD F1 Hybrid Hemp Seeds Flagship autoflower hemp seed variety designed for outdoor and mixed-light cultivation with shortened maturation times and extensive germplasm validation. First hemp seed released by Phylos.
- Phylos Natural THCV Varieties (GSD, Joyride, Powerhouse) Naturally-derived THCV cannabis varieties bred through modern plant breeding: Get Sh!t Done (GSD, 15.2% THCV), Joyride (14.5% THCV), and Powerhouse (19.8% THCV). First cannabis varieties with naturally-occurring high-THCV content, clinically validated through an IRB-approved People Science study.
- Natural Natural Ingredient Brand Consumer-facing ingredient brand powered by Phylos' patented naturally-derived rare cannabinoid genetics, supplying THCV ingredients and licensing to wholesale cultivators and consumer brands (Camino, Lost Farms, Heavy Hitters, Kanha, Airgraft, Garden Society, SHRED, Trailblazer, and others) across 10+ U.S. markets and Canada.
- Phylos Galaxy Interactive 3D genetic visualization and benchmarking platform featuring thousands of industrial hemp and cannabis DNA samples from 80+ countries, mapped to six sub-populations. Provides Genotype Reports showing identical clone matches, relational information, and breeding potential for growers, breeders, and researchers.
- Genotype Test Genomic testing service that validates cannabis and hemp strains by analyzing DNA at specific genomic points, generating genotype reports and assigning each variety a location within the Phylos Galaxy reference framework.
- Plant Sex Test Genomic testing service that identifies the male gene in cannabis plants at seedling stage, enabling growers and breeders to cull males early and improve operational efficiency.
Quantifiable outcome
- 55% reduction in labor hours with autoflower seeds due to no transplanting, minimal pruning, and streamlined scouting
- +9 more outcomes
Companies that use Phylos
Customer profileNamed customers7 records
Segments5 records
Ideal customer profiles3 records
Phylos technology and API
TechnologyTechnology focussed Yes
API detail
- Has API
- No
- API docs
- API detail
Core technology
AI maturity
App detail
Integration1 record
Feature9 records
Phylos partnerships and signals
Strategic signalPartnerships
Eight partnerships are on record, tiered core and minor.
- I Love Growing Marijuana (ILGM)coreExclusive partnership bringing 15 new F1 hybrid strains to home growers across legal U.S. markets through ILGM's online platform. Partnership leverages Phylos cutting-edge technology and extensive genetic library.
- People SciencecoreClinical research partnership conducting IRB-approved, double-blind study on THCV effects. Results demonstrated GSD significantly increased energy, activity, motivation, and well-being without munchies or fatigue.
- Wholesale THCV PartnerscorePacific Dutch Group and LEEF (CA); Ascend Wellness (IL, MA, NJ); The Pharm (AZ); Common Citizen (MI); Curio Wellness (MD); Schwazze (CO); Buddies (OR) - with expansion plans.
- Brand Partners (Natural Natural)coreYada Yada, Camino, Lost Farms, Heavy Hitters, Kanha, Airgraft, Garden Society (CA); SHRED, Trailblazer (Canada); HiDays (AZ); Tunnel Vision, Ozone (IL, MA, NJ); Good Day (MD); reV (MI); Kites, Buddies (OR); Moonlit Cannabis (WA).
- National Black Farmers AssociationminorPartnership to donate 1 million AutoCBD Hemp Seeds to BIPOC growers across the country, countering impact of war on drugs and building prosperity for disproportionately affected communities.
- Oregon State University (Global Hemp Innovation Center)minorPartner in 1 million hemp seed donation initiative for BIPOC farmers, providing scientific expertise and germplasm.
- Progressive Plant Research (PPR)coreDedicated research and cultivation partner with 80,000 sq ft glasshouse facility. PPR focuses on sustainable practices including partnership with Energy Trust of Oregon, Portland General Electric, and CLEAResult. Achieved 36% reduction in total energy use.
- IlluminacorePartnership with world's leading sequencing company to develop first cannabis genotyping array generating 50,000 unique data points per plant.
Scale indicators11 records
Recent moves6 records
Expansion highlights6 records
Phylos competitors and assessment
Company assessmentDirect peers
- Front Range Biosciences: Front Range Biosciences is a direct competitor in cannabis and hemp genetics, specializing in tissue culture propagation and disease-clean planting stock for cultivators. Both companies target commercial cannabis operators with science-driven genetics solutions and emphasize HLVd-free, uniform plant material.
- Trait Biosciences: Trait Biosciences is a cannabis biotechnology company developing proprietary cannabinoid genetics and seed-based production technologies. Like Phylos, Trait pursues IP-driven cannabis and hemp genetics with licensing and trait development as core revenue models.
Broad incumbents
- Canopy Growth Corporation: Canopy Growth is a large multi-state cannabis operator with internal genetics and breeding programs. While primarily a cultivator/retailer, its scale and capital could enable it to develop or acquire F1 hybrid seed technology comparable to Phylos.
- Aurora Cannabis: Aurora Cannabis is a vertically integrated cannabis producer with significant cultivation footprint and internal breeding operations. It operates across Canadian and international markets where Phylos has exclusivity deals via Organigram, making it an indirect competitor for global genetics supply.
- Cresco Labs: Cresco Labs is a U.S. multi-state cannabis operator with cultivation at scale and proprietary genetics. Its capital base and scale make it a potential acquirer or competitor to Phylos in supplying premium seeds to operators.
- Cronos Group: Cronos Group is a Canadian-licensed cannabis producer with international operations and prior investment in cannabinoid biotechnology (including a fermentation partnership with Ginkgo Bioworks). Its scale and biotech orientation make it a comparable cannabis operator.
- Royal Queen Seeds: Royal Queen Seeds is a leading European cannabis seed bank with global distribution. While more retail/home-grower focused than Phylos' commercial Elite Seeds, it is comparable as a branded cannabis seed company operating across multiple legal markets.
Others
- Organigram Global: Organigram is both Phylos' largest strategic investor ($10M debt-funded) and a customer via the Innovation Partner Program. While not a genetics competitor, Organigram represents Phylos' most concentrated single-counterparty exposure and is a vertically integrated cannabis operator.
- Hawthorne Gardening Company (Scotts Miracle-Gro): Hawthorne is Scotts Miracle-Gro's cannabis-focused cultivation supplies subsidiary, distributing nutrients, lighting, and genetics inputs to commercial growers. While not a direct seed-genetics competitor, Hawthorne's distribution scale and capital backing make it a potential channel or competitor in cannabis cultivation inputs.
Emerging players
- Demetrix: Demetrix is a cannabinoid biotech company using fermentation to produce rare cannabinoids (initially CBG) at scale. While Demetrix pursues synthetic-biology rather than plant-breeding approaches, both companies compete in supplying rare cannabinoid ingredients to consumer brands.
Market position
Strengths5 records
Weaknesses5 records
Competitive moat5 records
Key risks6 records
Key highlights7 records
Customer concentration
Phylos social profiles
Digital presencePhylos compliance and trust
Trust signalCompliance1 record
Phylos financial estimates
Financial estimateRevenue estimate
Valuation estimate
Phylos leadership team
Management profileNumber of profiles
Profiles12 records
Phylos subsidiaries and ownership
Company hierarchySubsidiaries1 record
Phylos funding detail
Funding detailFunding overview
Funding rounds9 records
Investors6 records
Funding detail is available on the Subscription and Enterprise plan.Contact sales →
Phylos M&A and investment
M&A and investmentM&A
Investments
M&A and investment is available on the Subscription and Enterprise plan.Contact sales →
Frequently asked questions about Phylos
What does Phylos do?
Phylos develops and sells premium F1 hybrid cannabis and hemp seeds (Production-Ready Seeds, Elite Seeds, AutoCBD, and autoflower varieties) using proprietary marker-assisted selection and DNA genotyping technology to deliver clone-quality uniformity from seed. The company also commercializes naturally-derived rare cannabinoid genetics (Phylos Natural THCV / Natural Natural brand) under licensing partnerships with consumer brands across multiple U.S. states and Canada.
Is Phylos a public or private company?
Phylos is a private company. It is classified as venture growth investor backed and is currently operating.
When was Phylos founded?
Phylos was founded in 2014. It employs 51 to 100 people.
Where is Phylos based?
Phylos is headquartered in Portland, United States, in the North America region.
How does Phylos make money?
Four revenue lines are on record. Seed Sales are the primary driver. The others are rare Cannabinoid Ingredients (Natural Natural Brand), variety Licensing and innovation Partnership Access.
Who are Phylos's main competitors?
Direct peers on record are Front Range Biosciences and Trait Biosciences. Broad incumbents are Canopy Growth Corporation, Aurora Cannabis, Cresco Labs, Cronos Group and Royal Queen Seeds. Others are Organigram Global and Hawthorne Gardening Company (Scotts Miracle-Gro). Demetrix is listed as an emerging player.
Does Phylos have an API?
No public API is recorded for Phylos.
What industry is Phylos in?
Phylos's product category is Cannabis Seed Genetics. Its primary akta.pro industry code is AFABALAJ, Seed Trait Licensing & IP Management (Licensing, freedom-to-operate), with a secondary code of AFABALAL, Digital Breeding & Bioinformatics Software (Breeding informatics, decision tools). Its NAICS code is 325411 and its SIC code is 6794.